This improvement in sleep has cascading benefits for recovery, energy, cognitive function, and even appetite regulation, since poor sleep is known to increase hunger hormones and cravings for high-calorie foods
This makes retatrutide a high-interest subject for studies involving non-alcoholic fatty liver disease (NAFLD) and metabolic-associated steatotic liver disease (MASLD), where glucagon activity is highly relevant
Zhang DM, Guo ZX, Zhao YL, et al
It promotes satiety and helps with blood sugar control but also slows down the entire gastrointestinal tract , leading to: Reduced peristalsis (gut contractions) Longer intestinal transit time Harder, drier stools Reduced Caloric and Fiber Intake Patients on GLP-1 medications often eat significantly less food due to appetite suppression
Instead of telling your clinician "I was nauseous," you can say "Nausea clustered in the first two days after my Friday shot, usually after larger meals, and improved when I ate smaller protein-first meals and drank more water." That is the kind of summary that makes tracking worth it and the kind your clinician needs to decide whether to step the dose up, hold, or adjust